INVESTINGBuffett Exits Phillips 66 and Travelers, Trims Goldman SachsBy Tom BemisMay 15, 2020 7:37 PM EDT
INVESTINGJetBlue Posts Wider-than-Expected Loss as Air Travel StifledBy Rob LenihanMay 7, 2020 2:49 PM EDT
INVESTINGBerkshire Hathaway Posts Loss of $50 Billion in First QuarterBy M. Corey GoldmanMay 2, 2020 9:17 AM EDT
INVESTINGBuffett’s Berkshire Hathaway Offloads Shares of DeltaBy M. Corey GoldmanApr 6, 2020 11:38 AM EDT
JIM CRAMERRough Road Ahead: Cramer's 'Mad Money' Recap (Friday 2/28/20)By Scott RuttFeb 28, 2020 8:53 PM EST
JIM CRAMERAll the Right Moves: Cramer's 'Mad Money' Recap (Tuesday 1/14/20)By Scott RuttJan 14, 2020 8:38 PM EST
INVESTINGIf U.S. Interest Rates Turn Negative, Here's Where You Should InvestBy Jason OrestesDec 10, 2019 2:45 PM EST
STOCKSBuffett's Berkshire Is Buying Restoration Hardware - Should You?By Bret KenwellNov 15, 2019 1:29 PM EST
VIDEOMay the Force Be With You? Jim Cramer on the JEDI Contract, and NvidiaBy Katherine RossNov 15, 2019 9:34 AM EST
INVESTINGWarren Buffett Adds RH Shares to Berkshire Hathaway Portfolio Filing ShowsBy Tom BemisNov 14, 2019 5:23 PM EST
STOCKSPG&E Shares Gain As Bankruptcy Judge Orders Mediation: ReportBy Tom BemisOct 29, 2019 4:11 PM EDT
STOCKSWarren Buffett Seeks Fed's OK to Boost Bank of America Stake Past 10% - ReportBy Tony OwusuOct 15, 2019 1:29 PM EDT
JIM CRAMERViacom, Berkshire Hathaway, Yeti: 'Mad Money' Lightning RoundBy Scott RuttAug 15, 2019 7:34 PM EDT
Video3 Things to Watch: Futures Point to Recovery, Amazon, Walmart Help Lift MarketsAug 15, 2019 9:04 AM EDT
MARKETSStocks Broadly Lower -- DJIA Down 2.9% -- as China Counters Trump Tariff EffortsBy Rob LenihanAug 5, 2019 4:20 PM EDT
MARKETSTrade Frictions Sink Stocks, China Devalues Yuan - 5 Things You Must KnowBy Joseph WoelfelAug 5, 2019 7:11 AM EDT
INVESTINGBerkshire Hathaway Posts $14 Billion in Net Earnings, Dip in Operating ProfitBy Adam SmithAug 4, 2019 1:20 PM EDT
INVESTINGBerkshire 'in Line' With Expectations for Q2: MorningstarBy Adam SmithAug 4, 2019 1:06 PM EDT
JIM CRAMERBerkshire Hathaway, Seattle Genetics, Zynerba: 'Mad Money' Lightning RoundBy Scott RuttJul 22, 2019 8:35 PM EDT
